Rumors Of Big Pharma Sales Force Cuts Could Boost Smaller Contracts For Ventiv

Small and mid-sized companies are more likely to seek contractors rather than enter into partnering deals with big pharma companies, Ventiv CEO Broshy says. Strong demand for CSO services is likely to continue among smaller companies as they make up a larger proportion of approved NDA holders.